Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma

Disease Markers
Seung Ji KangYoung Eun Joo

Abstract

This prospective observational study aimed at investigating the role of procalcitonin (PCT) in diagnosing bacterial infection and guiding antibiotic therapy for hepatocellular carcinoma (HCC) patients with fever after transarterial chemoembolization (TACE) and/or radiofrequency ablation (RFA). Ninety-seven cases (84 patients) were enrolled. Serum PCT, C-reactive protein (CRP), and white blood cell (WBC) counts were measured on the day of fever onset (day 0) and days 1, 3, 5, and 7 of fever. Empirical antibiotics were initiated only if PCT was ≥0.5 ng/mL or specific infection foci were suspected. An infectious cause was found in nine cases. PCT on day 0 of fever was significantly higher in patients with bacterial infection than in those without infection (P = 0.035). The area under the receiver operating characteristic curve for PCT was 0.715 (95% confidence interval, 0.538-0.892) and was higher than that for CRP (0.598 (0.368-0.828)) or WBC counts (0.502 (0.307-0.697)). In patients undergoing TACE and/or RFA, a significantly lower number of antibiotics were prescribed during the study period than during the prestudy period (P < 0.001). In conclusion, PCT might be a biomarker for diagnosing infection and guiding antibiotic treat...Continue Reading

References

May 26, 1998·Radiographics : a Review Publication of the Radiological Society of North America, Inc·I SakamotoN Matsunaga
Feb 20, 2003·Zeitschrift für Gastroenterologie·S ConnertC Elsing
Oct 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean-Francois DhainautDavid R Nelson
Dec 7, 2007·Journal of Vascular and Interventional Radiology : JVIR·Daniel B BrownMichael C Soulen
Dec 17, 2008·Scandinavian Journal of Gastroenterology·Chung-Pin LiShou-Dong Lee
Sep 8, 2009·European Journal of Radiology·P FilippousisL Thanos
Sep 29, 2009·The Korean Journal of Hepatology·UNKNOWN Korean Liver Cancer Study Group and National Cancer Center, Korea
Jan 25, 2013·World Journal of Gastroenterology : WJG·Chung Hwan JunJong Sun Rew
May 18, 2013·The Korean Journal of Internal Medicine·Hyuck Lee
Aug 28, 2014·Journal of Cancer Research and Clinical Oncology·P FitzmorrisA K Singal
Mar 3, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S H HoeboerA B J Groeneveld
Apr 9, 2015·Disease Markers·Christian LeliAntonella Mencacci
Apr 14, 2015·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Hesham K DabbousIman M F Montasser
Jul 4, 2017·Journal of Vascular and Interventional Radiology : JVIR·Ron C GabaUNKNOWN Society of Interventional Radiology Standards of Practice Committee

❮ Previous
Next ❯

Software Mentioned

Statistical Package for the Social Sciences ( SPSS / PC

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.